Table 1 Sociodemographic and clinical variables.
Schizophrenia group | Healthy control group | Group comparisons | P-value | |
|---|---|---|---|---|
Total N | 24 | 24 | ||
Gender/ Male N(%) | 17 (70.83) | 17 (70.83) | χ² (1, N) = 0.00 | p = 1.00 |
Age M(SD) | 31.28 (7.42) | 27.75 (4.94) | t(46) = −1.99 | p = 0.052 |
Education M(SD) | 12.88 (2.25) | 13.54 (2.02) | t(46) = 1.08 | p = 0.29 |
Symptoms | ||||
PANSS Negative M(SD) | 13.92 (5.66) | |||
PANSS Amotivation M(SD) | 5.92 (3.02) | |||
Planning time M(SD) | 431.54 (455.83) | 351.92 (200.74) | U = 276.00, z = 0.24 | p = 0.813 |
Planning errors M(SD) | 3.38(1.193 | 2.46 (1.77) | t(46) = −1.72 | p = 0.09 |
Working memory—raw score M(SD) | 17.58 (3.09) | 20.75 (3.95) | t(46) = 3.09 | p = 0.003 |
fNART premorbid IQ M(SD) | 106.52 (7.53) | 108.11 (8.84) | t(46) = 0.70 | p = 0.49 |
Weight (in kg) M(SD) | 80.69 | 67.46 (12.49) | t(46) = −3.18 | p = 0.003 |
Body Mass Index (BMI) M(SD) | 26.62 (4.39) | 22.37 (2.86) | t(46) = −3.97 | p < 0.001 |
Antipsychotic dosage (CPZ Eq) M(SD) | 547.92 (374.14) | |||
